AI assistant
Oncopeptides Major Shareholding Notification 2021
3091_iss_2021-10-26_160dcdb7-00af-47ff-af38-3f92978f57fe.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
Gladiator
Instrument
| Instrument | aktier SE0009414576 | |
|---|---|---|
| Before the transaction | ||
| Shares | 4,447,713 | |
| Voting rights | 4,447,713 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 26/10/2021 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 0 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 0 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | ||
| total holdings Group Voting rights 0 Percentage of voting rights 0 |
||
| Published 26/10/2021 17:44 |
||
| Contact | ||
| Name Max Mitteregger |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
Phone 0854504840 Email [email protected]